[Non-clear cell renal cell carcinoma: clinico-biological characteristics and therapeutic management except surgery]
Related Experiment Video
Updated: Dec 16, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Jonathan Thouvenin1, Philippe Barthélémy1, Sylvain Ladoire2
1Oncologie médicale, Hôpitaux universitaires de Strasbourg/Institut de Cancérologie Strasbourg Europe, 17, rue Albert-Calmette, 67200 Strasbourg, France.
Abstract:
Non-clear cell renal cell carcinomas (nccRCC) account for nearly 25% of all kidney cancers, and represent a group of highly heterogeneous tumors both in terms of histological varieties and also oncogenic biological abnormalities. The clinical presentation as well as the prognosis of the patients is also very variable. Given the rarity of each tumor entity, there are very few clinical trials that have focused on a well-defined variety of non-clear cell cancer. So, it is difficult to interpret these studies, and therefore to develop clear recommendations for medical management of advanced disease. In this article, the main clinico-biological characteristics, as well as a summary of the clinical results obtained in patients with nccRCC cancer, except surgery, will be presented.
More Related Videos
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi VI: Surgical Management
Targeted Cancer Therapies
There are several types of targeted therapies against...
Urinary Tract Calculi V: Nursing Management

